Literature DB >> 7645534

Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients.

C Shayakul1, L Ong-aj-yooth, P Chirawong, S Nimmannit, P Parichatikanond, T Laohapand, S Vasuvattakul, K Vareesangthip, S Vanichakarn, P Malasit.   

Abstract

The prognosis of lupus nephritis patients in Thailand has been reported to be poorer than that in Western countries since 1978. After a great evolution in management, we re-evaluate the long-term outcome in patients who were treated and followed up at Siriraj Hospital in Bangkok from 1984 to 1991. Clinical and pathologic records were collected from 569 patients (515 females and 54 men) who were followed up for a mean period of 38.7 +/- 34.6 months. The mean age was 28 +/- 10 years and the median duration of symptoms prior to admission was 7 months. Hypertension was diagnosed in 32.4% of patients and 41.3% had serum creatinine greater than 1.5 mg/dL. Nephrotic-range proteinuria was found in 43.6% of patients and creatinine clearance less than 50 mL/min was found in 58.0%. Of the 314 patients who underwent renal biopsy, the most common histologic finding was diffuse proliferative glomerulonephritis (61.5%). The overall probability of survival was 76.5% at 60 and 90 months after diagnosis. Initial presence of hypertension, renal insufficiency (creatinine clearance < 25 mL/min), and World Health Organization histology class IV and III in the biopsied patients were the three independent factors significantly associated with lower survival probability. Neither gender nor amount of proteinuria was the predictive factor for poor outcome. During the follow-up period, 89 patients died and two patients entered a chronic dialysis program. The two leading causes of death were infection (50.5%) and uremia (28.6%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7645534     DOI: 10.1016/0272-6386(95)90650-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Lupus Nephritis in Asia: Clinical Features and Management.

Authors:  Desmond Y H Yap; Tak Mao Chan
Journal:  Kidney Dis (Basel)       Date:  2015-08-05

2.  Treatment Results of Patients With Lupus Nephritis: A Single Center's Experience.

Authors:  Cahit Gunes; Mustafa Keles; Abdullah Uyanik; Ramazan Cetinkaya; Refik Ali Sari
Journal:  Eurasian J Med       Date:  2010-12

3.  Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.

Authors:  Abdurahman Saud Al Arfaj; Najma Khalil; Salman Al Saleh
Journal:  Rheumatol Int       Date:  2009-04-21       Impact factor: 2.631

4.  Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population.

Authors:  Zhaohui Zheng; Ruohan Yu; Congcong Gao; Xianan Jian; Songxia Quan; Guolan Xing; Shengyun Liu; Zhangsuo Liu
Journal:  Exp Ther Med       Date:  2017-08-30       Impact factor: 2.447

Review 5.  Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review.

Authors:  Wenjie Fang; Min Chen; Jia Liu; Ferry Hagen; Abdullah Ms; Peilian Zhang; Yun Guo; Teun Boekhout; Danqi Deng; Jianping Xu; Weihua Pan; Wanqing Liao
Journal:  Emerg Microbes Infect       Date:  2016-09-07       Impact factor: 7.163

6.  Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.

Authors:  Nellie Bourse Chalvon; Pauline Orquevaux; Delphine Giusti; Gregory Gatouillat; Thierry Tabary; Marcelle Tonye Libyh; Jan Chrusciel; Moustapha Drame; Grace Stockton-Bliard; Zahir Amoura; Laurent Arnaud; Hanns-Martin Lorenz; Gilles Blaison; Bernard Bonnotte; Nadine Magy-Bertrand; Sabine Revuz; Reinhard Edmund Voll; Oliver Hinschberger; Andreas Schwarting; Bach Nga Pham; Thierry Martin; Jean-Loup Pennaforte; Amelie Servettaz
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

7.  A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience.

Authors:  Sirirat Anutrakulchai; Thanachai Panaput; Jeerapat Wongchinsri; Somchai Chaishayanon; Bancha Satirapoj; Opas Traitanon; Warabhorn Pima; Chutima Rukrung; Bandit Thinkhamrop; Yingyos Avihingsanon
Journal:  Lupus Sci Med       Date:  2016-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.